Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.70K | 46.80K | 60.70K | 65.90K | 80.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.70K | 46.80K | 60.70K | 65.90K | 80.60K |
| Cost of Revenue | 25.10K | 21.60K | 28.00K | 31.70K | 39.10K |
| Gross Profit | 28.60K | 25.20K | 32.70K | 34.20K | 41.50K |
| SG&A Expenses | 231.10K | 328.30K | 363.70K | 406.40K | 458.30K |
| Depreciation & Amortization | 16.00K | 19.60K | 20.10K | 21.00K | 22.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 272.10K | 369.50K | 411.80K | 459.10K | 519.40K |
| Operating Income | -218.50K | -322.70K | -351.10K | -393.20K | -438.90K |
| Income Before Tax | -822.10K | -576.50K | -155.60K | -832.10K | -654.80K |
| Income Tax Expenses | 5.60K | 5.60K | 1.10K | 1.10K | 5.20K |
| Earnings from Continuing Operations | -0.83 | -0.58 | -0.16 | -0.83 | -0.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -827.70K | -582.10K | -156.70K | -833.20K | -660.00K |
| EBIT | -218.50K | -322.70K | -351.10K | -393.20K | -438.90K |
| EBITDA | -211.20K | -311.80K | -339.70K | -381.40K | -426.70K |
| EPS Basic | -0.03 | -0.02 | -0.01 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.02 | -0.01 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.40M |
| Average Diluted Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |